About the Journal

Focus and scope

The Australasian Journal of Plastic Surgery is a peer-reviewed, online-only journal established by the Australian Society of Plastic Surgeons and the Australasian Foundation for Plastic Surgery. This joint venture is enriched by the inclusion of the New Zealand Association of Plastic Surgeons.

The journal is published twice a year, in March and September, with the aim to increase the number of issues published per year in the future. The first issue of the journal was published in March 2018. 

The journal aims to: serve as a platform for the publication and dissemination of plastic and reconstructive surgery research and review in the form of original and review articles, case reports, editorials, letters to the editor, media reviews, perspectives, how to guides, practical non-clinical skills for surgeons, and video content; be a credible and legitimate source of information; support an environment that encourages and fosters ongoing research.

 

Peer review process

The Australasian Journal of Plastic Surgery reviews all material submitted. For original articles, review articles and case reports, the journal accepts open submissions and has adopted a double-blind peer review process. In this type of peer review, all identifying information is removed from the submission so that authors and reviewers remain anonymous to each other.

Editorials, letters to the editor, media reviews, perspectives, how to guides, practical non-clinical skills for surgeons, video content and features written by the journal’s own editorial staff do not undergo external peer review. Articles reporting original research conducted by journal editors are independently peer reviewed. If you experience any adverse event arising from double-blind peer review process, or would like to tell us your views, please email journal@plasticsurgery.org.au.

Information for reviewers can be found here.

 

Open Access Policy

The Australasian Journal of Plastic Surgery provides open access to peer reviewed research as part of its commitment to readers and authors. We make all our research articles freely available online and submit them directly to PubMed for indexing. Please note, as a new journal this process may be delayed until we have established a publishing record.

Authors retain copyright of their article and have a choice of publishing under the following Creative Commons Licence terms:

  • Creative Commons Attribution (CC BY) (recommended)
    Lets others distribute and copy the article, create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), include in a collective work (such as an anthology), text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honour or reputation.
  • Creative Commons Attribution Non-Commercial Licence (CC BY-NC)
    Lets others distribute, remix and build upon the work, but only if it is for non-commercial purposes and they credit the original creator/s (and any other nominated parties). 
  • Creative Commons Attribution-Non-commercial-NoDerivs (CC BY-NC-ND)
    For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article. 

 

Publication ethics

Submissions to the journal must conform to the International Committee of Medical Journal Editors' (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. These state the ethical principles in the conduct and reporting of research and provide recommendations relating to specific elements of editing and writing. Authors should be aware of the content of this document. In addition, the journal requires authors to comply with Best Practice Guidelines on Publication Ethics: A Publisher’s Perspective

Authorship and acknowledgements

The journal adheres to the definition of authorship by the ICMJE. The ICMJE recommends that authorship be based on the following four criteria: 

  1. Substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work; 
  2. Drafting the work or revising it critically for important intellectual content;
  3. Final approval of the version to be published; and
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’. If a submission has more than five authors, the inclusion of each name must be justified in the covering letter. Results of multicentre studies may be reported under the name of the organising group.

Reproduction of copyright material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the manuscript. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. 

Manuscripts with plagiarised content will not be considered by the journal. Authors who plagiarise  will be black-listed from the journal and reported back to their affiliated institutions.

Simultaneous submissions

The journal does not consider manuscripts that are simultaneously being considered by other journals. Occasionally, editors of different journals may knowingly agree to jointly publish selected articles because of the need for wide coverage. Examples include publication guidelines and important recommendations on public health. It is the responsibility of authors to ensure that two or more journals do not unknowingly publish the same article.

Redundant or duplicate publication

Redundant or duplicate publication occurs when a submission is published that overlaps substantially with one that has already been published in either print or electronic media. An article is reviewed for publication on the assumption that its contents have not been submitted simultaneously to another journal, have not been accepted for publication elsewhere and have not already been published.

The journal will consider manuscripts that have been rejected by another journal, that follow the publication of preliminary findings in the form of an abstract, or that provide supplementary information about a large complex study.

References must be provided for all publications that relate to the manuscript under consideration. In addition, copies of any possible duplicate published material should be submitted with a statement in the covering letter explaining why the manuscript under consideration is not a duplicate publication. This includes articles in press or under consideration by another journal. Any attempt at dual publication will lead to automatic rejection, may prejudice acceptance of future submissions, and may be highlighted in the journal.

Disclosure statement

Authors must declare any financial support or relationships that may pose conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the article is under review and will not influence the editorial decision. If the article is accepted for publication, the editor will usually discuss with the authors the manner in which such information is to be communicated to the reader. The conflict of interest form can be found here.

 

Research ethics

Declaration of Helsinki

Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil in October 2013). This approval must be declared in the Methods section of the article with inclusion of the name of the committee. In addition, patient anonymity must be preserved at all times. The journal will not publish pictures that identify patients unless the authors submit evidence of written consent from the patient or a legal guardian. The AJOPS Patient Consent form can be found here.

Use of animals in research

Reports of animal experiments must state that the principles of the care and use of animals for scientific purposes were followed, as well as any specific national laws where applicable.

Randomised controlled trials

Reporting of randomised controlled trials should follow the guidelines of The CONSORT Statement (Consolidated Standards of Reporting Trials).

Clinical trials

Clinical trials should be clearly identified as such in the title and abstract. A clinical trial is any study that prospectively assigns humans into groups to study the relationship between an intervention and a clinical outcome. Clinical trials should adhere to the guidelines outlined in the CONSORT Statement and all manuscripts must include a flow chart showing the progress of patients through the trial.

Clinical trial registration

The journal requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number in the acknowledgements section of their manuscript. If you wish the editor/s to consider an unregistered trial, please explain briefly why the trial has not been registered. 

Systematic reviews and meta-analyses

All systematic reviews of clinical trials must adhere to the guidelines outlined in the MOOSE report by the CONSORT Group. Authors should include a section describing the methods used for locating, selecting, extracting, and synthesising data. Authors are encouraged to use subheadings in the main text of the manuscript. The structured abstract should have the following sections: Background, Objectives, Data sources, Review methods, Results, and Conclusions.

All meta-analyses of randomised trials must adhere to the guidelines outlined in the PRISMA Statement1 which is designed to improve manuscript quality. Meta-analyses authors should review their papers against these guidelines before submission and can find the recommended PRISMA flow chart here and a sample check list here.

1 Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097

 

Privacy policy

Protecting your privacy is our top priority. Please read our Privacy Policy carefully to understand our views and practices regarding your personal information and how we will treat it.

 

Archiving

The journal utilises the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

 

Disclaimer

Statements and opinions expressed in the articles and communications herein, including comments made by readers, are those of the author(s) and not necessarily those of the editors, the Australian Society of Plastic Surgeons, Australasian Foundation for Plastic Surgery or the New Zealand Association of Plastic Surgeons.

The editorial team of the Australasian Journal of Plastic Surgery invites authors from any country to submit articles for publication on any aspect of plastic surgery. All manuscripts submitted to the journal are screened by the editors-in-chief. Manuscripts are immediately rejected if they are not in line with the aims of the journal, do not follow the Author Guidelines, or are well short of the standard required for publication.